GNE-431 is a potent, selective, and non-covalent "pan-BTK" inhibitor active against C481R, T474I, and T474M mutants; it shows inhibitory activity against wild-type BTK (IC50 = 3.2 nM) and the C481S mutant (IC50 = 2.5 nM); it holds promise for research in hematological disorders and autoimmune diseases.